Founded in 2024, Synthio Labs is building a clinical-grade conversational AI platform that transforms how life sciences companies engage with clinicians and patients. The company addresses a critical industry challenge: despite pharma companies spending over $30 billion annually on engagement, outreach remains manual, fragmented, and difficult to scale compliantly, contributing to treatment drop-off rates as high as 50% in long-term illnesses.

Synthio's AI Operating System unifies three AI products: Jarvis (voice AI copilot for field teams), Ather (multimodal engine for omnichannel physician and patient engagement), and Simulation Studio (digital twins for research and strategy).

Together, these HIPAA-compliant, SOC2-ready solutions are powering omnichannel engagement for global pharma and biotech teams.

Synthio Labs is defining the next major customer engagement infrastructure for life sciences, bringing consumer-grade experiences to an industry ready for transformation.